Laura Machin Galarza | Pharmacology | Young Scientist Award

Assist. Prof. Dr. Laura Machin Galarza | Pharmacology | Young Scientist Award

Laura Machin Galarza | University of Havana | Cuba

Dr. Laura Machin Galarza is an Assistant Professor and Researcher at the Institute of Pharmacy and Foods, University of Havana, specializing in pharmaceutical sciences and parasitology. She holds a Bachelor’s, Master’s, and Doctorate in Pharmaceutical Sciences from the University of Havana, where her academic journey has been marked by excellence and commitment to translational research. Dr. Machin has undertaken prestigious research stays at institutions in Austria, Germany, China, and Cuba, contributing to international collaborations focused on pharmacology, toxicology, and biopharmaceutical innovation. Her professional experience includes leadership in multidisciplinary projects exploring the antiprotozoal and antileishmanial potential of natural and synthetic compounds, advanced drug delivery systems, and pharmacological recycling strategies. She has authored multiple peer-reviewed publications in high-impact journals such as Pharmaceuticals, Molecules, and Experimental Parasitology, demonstrating expertise in medicinal chemistry and drug development. Dr. Machin’s work has been recognized through contributions to award-winning research honored by the Cuban Academy of Sciences. She actively serves in academic editorial processes, participates in professional scientific societies, and holds certifications that reflect her dedication to research excellence, innovation, and scientific leadership in the field of pharmaceutical sciences.

Profiles: Google Scholar | Scopus 

Featured Publications

1. B. Salehi, L. Machin, L. Monzote, J. Sharifi-Rad, S. M. Ezzat, M. A. Salem, et al., “Therapeutic potential of quercetin: new insights and perspectives for human health,” ACS Omega, vol. 5, no. 20, pp. 11849–11872, 2020.

2. B. Tamargo, L. Monzote, A. Piñón, L. Machín, M. García, R. Scull, W. N. Setzer, “In vitro and in vivo evaluation of essential oil from Artemisia absinthium L. formulated in nanocochleates against cutaneous leishmaniasis,” Medicines, vol. 4, no. 2, p. 38, 2017.

3. L. Machín, R. Nápoles, L. Gille, L. Monzote, “Leishmania amazonensis response to artemisinin and derivatives,” Parasitology International, vol. 80, p. 102218, 2021.

4. G. Geroldinger, M. Tonner, J. Quirgst, M. Walter, S. De Sarkar, L. Machín, et al., “Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: a possible link,” Biochemical Pharmacology, vol. 173, p. 113737, 2020.

5. L. Machín, B. Tamargo, A. Piñón, R. C. Atíes, R. Scull, W. N. Setzer, L. Monzote, “Bixa orellana L. (Bixaceae) and Dysphania ambrosioides (L.) Mosyakin & Clemants (Amaranthaceae) essential oils formulated in nanocochleates against Leishmania amazonensis,” Molecules, vol. 24, no. 23, p. 4222, 2019.

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Senior Consultant at Department of Oral and Maxillofacial Surgery / Plastic surgery, University Medicine Lübeck, Germany

Dr. med. Christian Seebauer, MD, DDS, is a distinguished clinician-scientist with dual qualifications in medicine and dentistry and board certifications in Oral and Maxillofacial Surgery and Oral Surgery. Currently a Senior Consultant at University Medical Center Lübeck, he has held several leadership roles in academic surgery. His research focuses on innovative therapies such as cold atmospheric plasma for cancer, wound healing, and oral diseases. He has authored impactful publications in high-ranking journals, with a strong emphasis on translational and interdisciplinary research. Awarded a summa cum laude for his medical doctorate, he is pursuing a second doctorate in dental medicine and a habilitation. Dr. Seebauer is actively involved in clinical trials, academic teaching, and scientific advising. His work reflects a commitment to advancing patient care through science, collaboration, and clinical excellence, making him a highly suitable candidate for prestigious research recognition such as the Best Researcher Award.

Professional Profile 

Google Scholar
Scopus Profile

Education

Dr. Christian Seebauer’s educational background reflects his exceptional commitment to interdisciplinary medical science. He earned his medical degree from Friedrich-Schiller-University Jena in 2006, graduating with high distinction and obtaining his medical license with a “very good” grade. Driven by an interest in craniofacial care, he pursued a second degree in dentistry at Ernst-Moritz-Arndt-University Greifswald, earning his dental license in 2015, again with top marks. He completed specialist training in Oral and Maxillofacial Surgery (2020) and Oral Surgery (2021), and is on track to receive an additional qualification in Plastic and Aesthetic Surgery by 2025. Academically, he achieved his Doctor of Medicine (summa cum laude) from Charité – Berlin in 2012, is completing a second doctorate in dental medicine, and is preparing his habilitation at University Medical Center Lübeck. His dual training uniquely equips him for complex surgical, academic, and translational roles in modern healthcare.

Professional Experience

Dr. Seebauer has accumulated extensive clinical and academic experience in leading German medical institutions. He began his residency in musculoskeletal surgery at Charité – Berlin (2007–2010), then transitioned into Oral and Maxillofacial Surgery at University Medical Centers in Jena and Greifswald. At Greifswald, he steadily advanced from resident to Specialist, then Senior Consultant, and eventually Managing Senior Consultant by 2023. In August 2024, he was appointed Senior Consultant at the University Medical Center Lübeck. Throughout his career, he has taken on multiple responsibilities beyond patient care, including roles in transfusion medicine, radiation safety, and medical coding. Dr. Seebauer is experienced in running clinical trials, mentoring young surgeons, and integrating advanced surgical techniques such as microvascular tissue transfer and plasma-based therapies. His professional trajectory demonstrates continuous growth in clinical leadership, academic excellence, and institutional trust, confirming his status as a respected authority in surgical and translational medicine.

Research Interest

Dr. Seebauer’s research centers on innovative, translational approaches to oral, mucosal, and dermal disease management, with a particular emphasis on cold atmospheric plasma. His work spans a range of high-impact medical themes, including wound healing, cancer therapy, precancerous lesions, chronic inflammation, and alternative cancer treatments. He has contributed significantly to both preclinical and clinical investigations, exploring how plasma technologies can improve outcomes in head and neck cancer, oral lichen planus, and leukoplakia. His recent studies include cohort analyses on the effects of anticoagulants on wound healing and the global impact of HPV vaccination on malignancy risks. He is actively involved in the planning of prospective, multicenter clinical trials and collaborates internationally via networks like TriNetX. His multidisciplinary approach combines surgery, oncology, immunology, and biomedical engineering, showcasing his ability to merge clinical insight with experimental innovation. These interests place him at the forefront of translational medical research in Europe.

Award and Honor

Dr. Christian Seebauer has earned several distinctions throughout his academic and clinical career. He was awarded his Doctor of Medicine degree summa cum laude, one of the highest academic honors in Germany, by the prestigious Charité – University Medical Center Berlin. His scientific work has been published in internationally renowned, peer-reviewed journals such as Radiology, Oral Diseases, and Pharmacological Research, some with impact factors exceeding 10. He has held trusted leadership roles, including Managing Senior Consultant, and serves as a Scientific Advisor to neoplas MED. His selection for these positions reflects institutional recognition of his scientific and clinical integrity. Although not explicitly listed, his rising trajectory in academic medicine and involvement in high-level research projects suggest a strong reputation within professional circles. His affiliations with organizations such as the National Center for Plasma Medicine and Rotary Club also highlight his commitment to service and excellence beyond his clinical duties.

Conclusion

Dr. Christian Seebauer exemplifies the ideal candidate for recognition as a Best Researcher. With dual qualifications in medicine and dentistry, a track record of clinical leadership, and a deep commitment to translational research, he bridges the gap between scientific discovery and patient care. His pioneering work in cold atmospheric plasma and its applications in oncology and regenerative medicine is both innovative and impactful, reflecting future-forward thinking in clinical science. His publication record, leadership roles, and collaborative involvement in global research initiatives further establish his credibility and influence in the medical community. Dr. Seebauer’s academic path—marked by excellence, versatility, and continual advancement—underscores his dedication to improving healthcare through research, education, and clinical innovation. As he continues his habilitation and leads new clinical trials, his contributions are poised to shape future standards in surgery and therapeutic technology. He is highly deserving of prestigious accolades such as the Best Researcher Award.

Publications Top Notes

  • Title: Clinical experience with cold plasma in the treatment of locally advanced head and neck cancer

    • Authors: HR Metelmann, C Seebauer, V Miller, A Fridman, G Bauer, DB Graves, …

    • Year: 2018

    • Citations: 353

  • Title: Head and neck cancer treatment and physical plasma

    • Authors: HR Metelmann, DS Nedrelow, C Seebauer, M Schuster, T von Woedtke, …

    • Year: 2015

    • Citations: 256

  • Title: Molecular mechanisms of the efficacy of cold atmospheric pressure plasma (CAP) in cancer treatment

    • Authors: ML Semmler, S Bekeschus, M Schäfer, T Bernhardt, T Fischer, K Witzke, …

    • Year: 2020

    • Citations: 216

  • Title: Comprehensive clinical plasma medicine: cold physical plasma for medical application

    • Authors: HR Metelmann, T Von Woedtke, KD Weltmann

    • Year: 2018

    • Citations: 162

  • Title: Visible tumor surface response to physical plasma and apoptotic cell kill in head and neck cancer

    • Authors: M Schuster, C Seebauer, R Rutkowski, A Hauschild, F Podmelle, …

    • Year: 2016

    • Citations: 152

  • Title: Cold atmospheric pressure plasma in wound healing and cancer treatment

    • Authors: L Boeckmann, M Schäfer, T Bernhardt, ML Semmler, O Jung, G Ojak, …

    • Year: 2020

    • Citations: 100

  • Title: Treating cancer with cold physical plasma: On the way to evidence‐based medicine

    • Authors: HR Metelmann, C Seebauer, R Rutkowski, M Schuster, S Bekeschus, …

    • Year: 2018

    • Citations: 65

  • Title: Hyperspectral imaging for in vivo monitoring of cold atmospheric plasma effects on microcirculation in treatment of head and neck cancer and wound healing

    • Authors: R Rutkowski, M Schuster, J Unger, C Seebauer, HR Metelmann, …

    • Year: 2017

    • Citations: 58

  • Title: Ankle laxity: stress investigation under MRI control

    • Authors: CJ Seebauer, HJ Bail, JC Rump, B Hamm, T Walter, UKM Teichgräber

    • Year: 2013

    • Citations: 55

  • Title: Side effects in cold plasma treatment of advanced oral cancer—Clinical data and biological interpretation

    • Authors: M Schuster, R Rutkowski, A Hauschild, RK Shojaei, T von Woedtke, …

    • Year: 2018

    • Citations: 48

  • Title: Physical plasma and leukocytes–immune or reactive?

    • Authors: S Bekeschus, C Seebauer, K Wende, A Schmidt

    • Year: 2018

    • Citations: 42

  • Title: Plasmamedizin

    • Authors: HR Metelmann, T von Woedtke, KD Weltmann

    • Year: 2016

    • Citations: 42

  • Title: Cold argon plasma as adjuvant tumour therapy on progressive head and neck cancer: A preclinical study

    • Authors: S Hasse, C Seebauer, K Wende, A Schmidt, HR Metelmann, …

    • Year: 2019

    • Citations: 41

  • Title: Third molars and periodontal damage of second molars in the general population

    • Authors: S Kindler, B Holtfreter, T Koppe, M Mksoud, C Lucas, C Seebauer, …

    • Year: 2018

    • Citations: 36

  • Title: Plasma-derived reactive species shape a differentiation profile in human monocytes

    • Authors: E Freund, J Moritz, M Stope, C Seebauer, A Schmidt, S Bekeschus

    • Year: 2019

    • Citations: 34

Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Prof. Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

department leader at West Anhui University, China

Professor Chen, born in September 1972 in Jinzhai County, Anhui Province, is a distinguished scholar and a leading figure in the field of traditional Chinese medicine and natural product research. Currently, he serves as a Distinguished Professor (Dabieshan Scholar) at West Anhui University, where he also holds multiple leadership roles, including Deputy Director of the Experimental Teaching and Training Management Department, and Director of the Postdoctoral Research Workstation. He is a doctoral supervisor affiliated with Anhui University of Chinese Medicine and Anhui Agricultural University, and leads the Anhui Provincial Key Laboratory of Traditional Chinese Medicine Quality Evaluation and Enhancement. Prof. Chen is also the head of several strategic research teams and innovation platforms that focus on the modernization and industrialization of herbal medicine. A nationally recognized talent under the Anhui Provincial Special Support Plan, he has been honored as a Top Talent of Lu’an City, Outstanding Teaching Faculty of West Anhui University, and nominee for Lu’an Distinguished Talent Award. His scholarly influence is reinforced by his role as a reviewer for the National Natural Science Foundation and active participation in national academic societies, contributing to both academic and practical advancements in pharmaceutical science.

Professional Profile

Education

Professor Chen holds a PhD in Pharmaceutical Sciences, which provided the foundation for his career-long dedication to the research and development of traditional Chinese medicine. With a strong academic background rooted in pharmacy, chemistry, and biotechnology, his educational journey integrated classical medicinal knowledge with modern scientific methodology. Over the years, he has further enhanced his qualifications through postdoctoral research and continuous academic training, establishing himself as a multidisciplinary expert. His early education fostered a strong commitment to scientific excellence and innovation, particularly in areas such as medicinal chemistry, pharmacology, and natural product extraction. His academic milestones have been complemented by hands-on experience in laboratory work, clinical trials, and academic leadership. Prof. Chen’s teaching and mentorship roles at institutions such as Anhui University of Chinese Medicine and Anhui Agricultural University reflect a solid academic lineage and dedication to nurturing the next generation of researchers. His consistent academic growth, paired with strategic collaboration with scientific institutions, has enabled him to contribute meaningfully to the evolving landscape of pharmaceutical education in China. His educational achievements form the intellectual backbone of his extensive work in TCM standardization, drug development, and plant-based biomedicine.

Professional Experience

Throughout his career, Professor Chen has accumulated a wealth of professional experience spanning academia, research administration, and national-level scientific leadership. As a Professor at West Anhui University, he has played a pivotal role in curriculum development, talent cultivation, and institutional research strategy. He concurrently serves as Vice Secretary of the Party Committee and Deputy Director of the Experimental Training Management Department, while also leading the Postdoctoral Workstation and provincial laboratories in quality enhancement of traditional Chinese medicine. Prof. Chen is the Chief Investigator and Team Leader of several key innovation teams focused on medicinal plant research and pharmacological innovation. Beyond his university, he is deeply involved in provincial and national science policymaking, contributing as a Communications Reviewer for NSFC, and as a standing member of the Chinese Under-Forest Economy Society and Anhui Botanical Society. Over the years, he has led or participated in over 20 major scientific research projects, with total funding in the multimillion-yuan range. His work often bridges the gap between academia and industry, evidenced by extensive industry-academic collaboration, numerous patents, and standard-setting activities. His experience reflects a mature balance of teaching, research, and service that defines his leadership in Chinese pharmaceutical sciences.

Research Interests

Professor Chen research interests center on the quality evaluation, efficacy enhancement, and innovation of traditional Chinese medicines (TCMs). A key focus of his work is the phytochemistry, pharmacokinetics, and bioactivity of medicinal herbs, particularly Dendrobium huoshanense, a rare and valuable plant species. His investigations delve into metabolomics, network pharmacology, and structure-activity relationships, aiming to improve standardization and therapeutic potential of herbal products. He has also led efforts to decode the geographical specificity (daodi) and biological transformation mechanisms of active components in medicinal plants. His interest in synergistic fermentation, antioxidant activity, and enzyme inhibition studies has resulted in innovative methods for improving bioavailability and therapeutic outcomes of plant-based compounds. Additionally, Professor Chen integrates modern analytical technologies such as UPLC-MS/MS, NIR spectroscopy, and bioinformatics into his research toolkit, enhancing the precision and scalability of TCM research. His collaborative work with pharmaceutical companies aims to commercialize novel herbal formulations and functional health products. As TCM gains global interest, Prof. Chen’s research aligns with the trend of merging traditional knowledge with cutting-edge biomedical science, addressing critical issues in herbal medicine safety, efficacy, and modernization.

Awards and Honors

Professor Chen has been recognized with numerous prestigious awards and honors, reflecting his profound impact on pharmaceutical research and education. Among his most notable achievements are two Second Prizes for Science and Technology Progress in Anhui Province and the Special Award for Technological Advancement by the China General Chamber of Commerce. These accolades signify his contributions to both fundamental science and its practical application in the modernization of traditional Chinese medicine. He was also honored with the Anhui Provincial Teaching Achievement Award (Second Prize), highlighting his role in academic innovation and pedagogy. As a recipient of the Anhui Provincial Leading Talent under the Special Support Plan, Prof. Chen is acknowledged as a strategic scientific leader. He has been awarded Top Talent and Outstanding Scholar titles in Lu’an City, and recognized as a Teaching Master at West Anhui University. His selection as Principal Investigator for National Natural Science Foundation of China (NSFC) projects further underscores his status in China’s scientific community. With over 40 patent applications, 23 industry and local standards developed, and extensive mentorship roles, his accolades are both deep and diverse. These honors confirm his legacy as a highly influential and respected figure in biomedical and TCM research.

Conclusion

Professor 陈乃东 is a highly suitable candidate for the Best Researcher Award. His outstanding achievements in TCM quality research, natural products pharmacology, and regional development through science and innovation reflect the hallmarks of a leading researcher. His contributions are scientifically rigorous, socially relevant, and academically influential. With minor enhancements in global engagement and innovation translation, his profile could further stand out on the world stage.

Publications Top Notes

  • Author(s): Hao, Jingwen; Wang, Weiting; Chen, Naidong; Shen, Yan
    Year: 2025
    Title: Identification of 13 natural antioxidants in green calyx plum using AAPH, ABTS, and FRAP-coupled HPLC-DAD via QTOF-MS/MS
    Journal: Food Chemistry
    Citations: 0

  • Author(s): Chen, Naidong
    Year: 2025
    Title: Mechanism for the Inhibition of α-Glucosidase by Peptide Tyr-Pro-Ile-Trp (YPIW) and Its Stability
    Journal: Shipin Kexue / Food Science
    Citations: 0

  • Author(s): Zheng, Shaojun; Li, Sheng; Diao, Xiaohan; Chen, Naidong
    Year: 2025
    Title: Prunus mume Alleviates Hyperuricemic Renal Injury: Insights From Network Pharmacology and Experimental Models
    Journal: Biomedical Chromatography
    Citations: 0

  • Author(s): Hao, Kuku; Wang, Qijin; Wei, Shengxiang; Zheng, Shaojun; Zhang, Manman; Chen, Naidong (co-author)
    Year: 2025
    Title: Structural characterization and anti-inflammatory activity of a neutral polysaccharide from Dendrobium huoshanense C. Z. Tang et S. J. Cheng
    Journal: International Journal of Biological Macromolecules
    Citations: 0

  • Author(s): Hao, Jingwen; Fan, Xuanxuan; Chen, Naidong; Xiao, Jun; Zhang, Manman
    Year: 2025
    Title: A novel method for the simultaneous determination of flavonoids in Pteridium aquilinum via SPE combined with UPLC-DAD via QAMS
    Journal: Journal of Food Composition and Analysis
    Citations: 0